<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jacobson, Anne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Henry, Ronald</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">CLARIFY and Its Relevance to the Caribbean Population</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">12-13</style></pages><abstract><style  face="normal" font="default" size="100%">The Prospective Observational Longitudinal Registry of Patients with Stable Coronary Artery Disease [CLARIFY] study is a large (n=31,040) international trial that is aimed at evaluating outcomes and long-term prognostic determinants in outpatients with stable coronary artery disease, including heart rate, that adequately represent this contemporary population worldwide. This article discusses the significance of the CLARIFY trial as it applies to the Caribbean.</style></abstract><number><style face="normal" font="default" size="100%">7</style></number><volume><style face="normal" font="default" size="100%">10</style></volume></record></records></xml>